Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.

Clinical trial NCT05226702 · COMPLETED

Trial details

NCT number: NCT05226702
Sponsor: University of Saskatchewan
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Double Vaccinated for COVID-19 (For Phase 1 of the Study)Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)

Start date: 2022-07-22
Primary completion: 2023-11-13
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.